Loading
Latest filing published 25 Jan 2022 for Green Vision Biotechnology CORP., €199k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kwong Tak Leung discloses dealings in Green Vision Biotechnology Corp. to SEC (Form 4). Between 19 January 2021 and 17 January 2022, the trades on record add up to 5 filings.
The open-market side counts 2 purchases for €12k alongside 3 sales for €261k. On balance, insiders were net sellers of €249k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2022, the count stands at no purchases and 1 sale.
The record was last updated on 25 January 2022 with an open-market sale (€199k) in Green Vision Biotechnology Corp. The last purchase on record was published on 1 September 2021, which is 1,879 days ago. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations